secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIGAND PHARMACEUTICALS INC (LGND)
CIK:        0000886163
Form:       8-K
Filed at:   2026-05-18T13:01:36+00:00
Accession:  0001193125-26-228003
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ligand and XOMA Royalty amend merger agreement to add HoldCo as party
---------------------------------------------------------------------

- Amendment No. 1 dated May 16, 2026, adds XOMA Royalty Holdings Corp as a party to the merger agreement.
- HoldCo was formed on May 15, 2026 to facilitate the holding company reorganization under Nevada law.
- Changes are technical, including joinder of HoldCo and minor section amendments; deal value/terms unchanged.
- The merger was previously announced on April 27, 2026; transaction conditions remain the same.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886163/000119312526228003/0001193125-26-228003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886163/000119312526228003/d86489d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-228003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer